Zobrazeno 1 - 10
of 3 658
pro vyhledávání: '"human rotavirus vaccine"'
Autor:
Fukuda, Saori1 (AUTHOR) saorif@fujita-hu.ac.jp, Kugita, Masanori2 (AUTHOR) m-kugi@fujita-hu.ac.jp, Kumamoto, Kanako2 (AUTHOR) kumamoto@fujita-hu.ac.jp, Akari, Yuki1,3 (AUTHOR) m24d9001@oita-u.ac.jp, Higashimoto, Yuki4,5 (AUTHOR) tetsushi@fujita-hu.ac.jp, Nagao, Shizuko2 (AUTHOR) shizun@fujita-hu.ac.jp, Murata, Takayuki1,6 (AUTHOR) tmurata@fujita-hu.ac.jp, Yoshikawa, Tetsushi5,6 (AUTHOR), Taniguchi, Koki1 (AUTHOR) kokitani@fujita-hu.ac.jp, Komoto, Satoshi1,3,6 (AUTHOR) satoshik@oita-u.ac.jp
Publikováno v:
Viruses (1999-4915). Aug2024, Vol. 16 Issue 8, p1198. 14p.
Autor:
Saori Fukuda, Masanori Kugita, Kanako Kumamoto, Yuki Akari, Yuki Higashimoto, Shizuko Nagao, Takayuki Murata, Tetsushi Yoshikawa, Koki Taniguchi, Satoshi Komoto
Publikováno v:
Viruses, Vol 16, Iss 8, p 1198 (2024)
The live attenuated human rotavirus vaccine strain RIX4414 (Rotarix®) is used worldwide to prevent severe rotavirus-induced diarrhea in infants. This strain was attenuated through the cell culture passaging of its predecessor, human strain 89-12, wh
Externí odkaz:
https://doaj.org/article/3a7422a463114020bd489b9a564a38c9
Autor:
Surasak Saokaew, Wasana Prasitsuebsai, Gyneth Lourdes Bibera, Kirati Kengkla, Xu-Hao Zhang, Kyu-Bin Oh, Christa Lee
Publikováno v:
Infectious Diseases and Therapy, Vol 8, Iss 3, Pp 397-415 (2019)
Abstract Introduction Rotavirus gastroenteritis is the leading cause of severe diarrhoea among young children < 5 years old. Previous cost-effectiveness analyses on rotavirus (RV) vaccination in Thailand have generated conflicting results. The aim of
Externí odkaz:
https://doaj.org/article/2b9774051b724860a59d139b0ffcec83
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Armah, George, Lewis, Kristen D. C., Cortese, Margaret M., Parashar, Umesh D., Ansah, Akosua, Gazley, Lauren, Victor, John C., McNeal, Monica M., Binka, Fred, Steele, A. Duncan
Publikováno v:
The Journal of Infectious Diseases, 2016 Jun 01. 213(11), 1678-1685.
Externí odkaz:
http://www.jstor.org/stable/24717635
Autor:
Catherine Cohet, Brigitte Cheuvart, Leentje Moerman, Dan Bi, Adrian Caplanusi, Mallesh Kariyappa, Sanjay Lalwani, Monjori Mitra, Amita Sapru, Shruti Saha, P.V. Varughese, Rajeev Zachariah Kompithra, Sanjay Gandhi
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 11, Pp 4646-4653 (2021)
The human rotavirus vaccine (HRV; Rotarix, GSK) is available as liquid (Liq) and lyophilized (Lyo) formulations, but only Lyo HRV is licensed in India. In this phase III, randomized, open-label trial (NCT02141204), healthy Indian infants aged 6–10
Externí odkaz:
https://doaj.org/article/5d35f76d2617450b9901c97811e1abfb
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alen Marijam, Lode Schuerman, Patricia Izurieta, Priya Pereira, Désirée Van Oorschot, Shailesh Mehta, Martin OC Ota, Baudouin Standaert
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 7 (2022)
Vaccine impact models against rotavirus disease (RD) and pneumococcal disease (PD) in low- and middle-income countries assume vaccine coverage based on other vaccines. We propose to assess the impact on severe disease cases and deaths avoided based o
Externí odkaz:
https://doaj.org/article/afd6497327b841c0864297205ae2eb94
Autor:
Armah
Publikováno v:
The Journal of Infectious Diseases, 2016 Oct 01. 214(7), 1127-1127.
Externí odkaz:
http://www.jstor.org/stable/44007201
Autor:
Moon, Sung-Sil, Groome, Michelle J., Velasquez, Daniel E., Parashar, Umesh D., Jones, Stephanie, Koen, Antoinette, van Niekerk, Nadia, Jiang, Baoming, Madhi, Shabir A.
Publikováno v:
Clinical Infectious Diseases, 2016 Jan . 62(2), 157-165.
Externí odkaz:
https://www.jstor.org/stable/26370141